What are the side effects of Concerta (extended‑release methylphenidate)?

Concerta Side Effects

Concerta (extended-release methylphenidate) commonly causes decreased appetite, headache, dry mouth, nausea, insomnia, anxiety, dizziness, weight loss, irritability, and increased sweating in adults, while children most frequently experience upper abdominal pain. 1

Most Common Side Effects by Age Group

Adults

• Decreased appetite – one of the most frequently reported adverse effects 1
• Headache – very common complaint during treatment 1
• Dry mouth – significantly more common than with some alternative ADHD medications 1, 2
• Nausea – frequently reported gastrointestinal effect 1
• Insomnia (trouble sleeping) – substantially more common than with non-stimulant alternatives, with one comparative study showing 11% higher risk versus centanafadine 1, 2
• Anxiety – occurs in a notable proportion of patients 1
• Dizziness – common neurological side effect 1
• Weight loss – expected consequence of appetite suppression 1
• Irritability – behavioral side effect during treatment 1
• Increased sweating – autonomic nervous system effect 1

Children and Adolescents

• Upper abdominal pain – the single most common side effect in pediatric patients 1
• All adult side effects listed above can also occur in children 1

Serious Side Effects Requiring Immediate Medical Attention

Cardiovascular Complications

• Sudden death – has occurred in patients with pre-existing heart defects or serious heart disease 1
• Increased blood pressure and heart rate – requires regular monitoring throughout treatment 1
• Chest pain, shortness of breath, or fainting – warrant immediate emergency evaluation 1
• Peripheral vasculopathy (Raynaud's phenomenon) – fingers or toes may feel numb, cool, or painful; may change color from pale to blue to red 1
• Unexplained wounds on fingers or toes – require immediate physician contact 1

Psychiatric Adverse Events

• New or worsening psychotic symptoms – including hearing voices or seeing/believing things that are not real 1
• New or worsening manic symptoms – even in patients without prior bipolar illness 1
• New or worsening behavioral or thought problems 1
• Depression – uncommon but documented; one case report described depressive symptomatology emerging after dose increase in a 7-year-old 3
• Agitation and suicidal ideation – have been reported in the literature 4

Neurological Complications

• Seizures – treatment should be stopped if seizures occur 1
• New or worsening tics or Tourette's syndrome – requires notification of healthcare provider 1

Other Serious Effects

• Priapism (painful and prolonged erections) – may require surgical intervention; seek immediate medical help 1
• Eye problems – increased intraocular pressure and glaucoma; report vision changes, eye pain, swelling, or redness immediately 1
• Eyesight changes or blurred vision 1
• Possible intestinal blockage – Concerta should not be used in patients with severe gastrointestinal narrowing 1

Growth and Development Effects in Children

• Slowing of height and weight gain – children require frequent monitoring of growth parameters during treatment 1
• Treatment may need to be stopped if the child is not growing or gaining weight as expected 1

Abuse, Misuse, and Dependence Risk

• High potential for abuse and misuse – Concerta is a Schedule II controlled substance 1
• Risk of addiction – can lead to substance use problems including physical dependence 1
• Overdose and death risk – increased with higher doses or non-approved routes of administration (snorting, injection) 1
• Must be stored securely and never shared with others 1

Comparative Safety Profile

When compared to other ADHD medications, methylphenidate extended-release (Concerta) shows:

• Significantly higher rates of dry mouth (approximately 12 percentage points higher), insomnia (11% higher), decreased appetite (8% higher), anxiety (5% higher), palpitations (5% higher), and feeling jittery (5% higher) compared to centanafadine 2
• Similar adverse event profile to immediate-release methylphenidate given three times daily, with equivalent tolerability 5
• Common adverse events include insomnia, anorexia (odds ratio 5.11 vs placebo), abdominal pain, and headache (14% of participants) 6

Important Clinical Considerations

Timing and Dose-Related Patterns

• Many adverse events occur early in treatment (52% reported within 30 days) and at lower doses (54% at 20-40 mg) 7
• In real-world practice, clinicians often discontinue treatment after adverse event onset, whereas clinical trial data suggest many adverse events are manageable with continued dose optimization 7

Normal Tablet Appearance in Stool

• The empty Concerta tablet shell may be visible in bowel movements after the medication has been released – this is normal and expected 1

Critical Pitfalls to Avoid

• Do not discontinue immediately upon first adverse event – trial data demonstrate that many tolerability issues can be managed with dose adjustment or timing changes rather than discontinuation 7
• Do not ignore cardiovascular screening – baseline and ongoing blood pressure and heart rate monitoring are essential 1
• Do not overlook psychiatric history – patients or family members with bipolar disorder, mania, or depression require careful monitoring for symptom exacerbation 1
• Do not crush, chew, or divide tablets – Concerta must be swallowed whole to maintain its extended-release properties 1